590 filings
Page 9 of 30
4
0c1d9kf7kjq945c1xm
17 Dec 20
9 METERS BIOPHARMA / Mark A Sirgo ownership change
4:17pm
4
353t3q1mqcb9md
17 Dec 20
9 METERS BIOPHARMA / Edward J Sitar ownership change
4:17pm
SC 13D/A
evc5zhrrlvvs
16 Dec 20
9 METERS BIOPHARMA / OrbiMed Israel BioFund GP Limited Partnership ownership change
5:13pm
8-K
hwl4jmbv
15 Dec 20
9 Meters Biopharma, Inc. Announces Proposed Public Offering of Common Stock
4:25pm
424B5
m30rset6q qub1zy
11 Dec 20
Prospectus supplement for primary offering
5:27pm
424B5
gzpctye c7td
10 Dec 20
Prospectus supplement for primary offering
4:09pm
SC 13G/A
1a7a0qy12i j53jmtq
10 Dec 20
9 METERS BIOPHARMA / Capital Point ownership change
10:58am
8-K
75rp xnefw8kyp
9 Dec 20
Other Events
7:34am
8-K
f0dzr9fenjr1p 9wbf
7 Dec 20
Other Events
7:40am
8-K
vtrbg476 i9t
7 Dec 20
9 Meters Biopharma, Inc. Announces Positive Topline Data for NM-002, a Proprietary Long-Acting GLP-1, in Phase 1b/2a Trial for Short Bowel Syndrome
7:37am
4
kdhbj
1 Dec 20
9 METERS BIOPHARMA / John Temperato ownership change
4:10pm
8-K
613 31ql80
27 Nov 20
Departure of Directors or Certain Officers
4:07pm
8-K
v4ftm5jss hy2pvj3cc
16 Nov 20
9 Meters Biopharma Announces Positive Preclinical Data for NM-102, a Gut Microbiome Modulator in an Immune Checkpoint Inhibitor Failure Model
7:51am
8-K
0k7ndwpu573 dfm9ws
9 Nov 20
9 Meters Biopharma, Inc. Provides Business Update and Announces Third Quarter 2020 Results
8:04am
4
cfuk541s zf813gyxcu
3 Nov 20
Change in insider ownership
4:14pm
4
erq898c6f
3 Nov 20
9 METERS BIOPHARMA / Nissim Darvish ownership change
4:14pm
4
l7aq5kyb
3 Nov 20
9 METERS BIOPHARMA / Mark A Sirgo ownership change
4:14pm
4
00m vvaad0kc52z
3 Nov 20
9 METERS BIOPHARMA / John Temperato ownership change
4:13pm
8-K
mu2n74
2 Nov 20
9 Meters Biopharma, Inc. to participate in the following November
8:09am